We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.00%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $42.67 · 3 analysts
Stored first · Google News · Yahoo Finance (English)
Opaleye management sells $1.06m Eton Pharmaceuticals stock - Investing.com
Opaleye management sells $1.06m Eton Pharmaceuticals stock Investing.com
Form 4 Eton Pharmaceuticals Inc For: 16 July By Investing.com - Investing.com Canada
Form 4 Eton Pharmaceuticals Inc For: 16 July By Investing.com Investing.com Canada
Eton Pharmaceuticals (ETON) holder Opaleye reports July stock sales - Stock Titan
Eton Pharmaceuticals (ETON) holder Opaleye reports July stock sales Stock Titan
Eton Pharmaceuticals stock hits all-time high at 38.76 USD By Investing.com - Investing.com Canada
Eton Pharmaceuticals stock hits all-time high at 38.76 USD By Investing.com Investing.com Canada
Eton Pharmaceuticals (ETON) Could Be 18% Undervalued As Valuation Questions Build - simplywall.st
Eton Pharmaceuticals (ETON) Could Be 18% Undervalued As Valuation Questions Build simplywall.st
Form 4 Eton Pharmaceuticals Inc For: 14 July By Investing.com - Investing.com UK
Form 4 Eton Pharmaceuticals Inc For: 14 July By Investing.com Investing.com UK
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 08. 06. | After market close (AMC) | $0.19 | — | — | $26.88M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.06 | — | — | $17.28M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.12 | — | — | $27.36M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | — | — | — | $17.04M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 16. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 21. | B. Riley Securities | — | Maintain | Buy → Buy | — | B. Riley Securities: Buy |
| 2026. 03. 21. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 03. 21. | Craig-Hallum | — | Maintain | Buy → Buy | — | Craig-Hallum: Buy |
| 2026. 03. 03. | Craig-Hallum | — | Maintain | Buy → Buy | — | Craig-Hallum: Buy |
| 2026. 03. 02. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 106,393 | $2.63M | 0.00% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 76,602 | $1.3M | 0.00% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 12,925 | $218.56K | 0.00% | — | New position |